Increased Citrullination of Histone H3 in Multiple Sclerosis Brain and Animal Models of Demyelination: A Role for Tumor Necrosis Factor-Induced Peptidylarginine Deiminase 4 Translocation
暂无分享,去创建一个
Reinout Raijmakers | Jiang Mei | R. Raijmakers | L. Probert | F. Mastronardi | D. Wood | J. Mei | V. Tseveleki | H. Dosch | P. Casaccia‐Bonnefil | M. Moscarello | Patrizia Casaccia-Bonnefil | Fabrizio G Mastronardi | D Denise Wood | Vivian Tseveleki | Hans-Michael Dosch | Lesley Probert | Mario A Moscarello | Reinout Raijmakers
[1] Aaron J. Johnson,et al. The role of CD8+ T-cells in lesion formation and axonal dysfunction in multiple sclerosis , 2006, Neurological research.
[2] S. Ludwin,et al. The Pathogenesis of Multiple Sclerosis: Relating Human Pathology to Experimental Studies , 2006, Journal of neuropathology and experimental neurology.
[3] L. Klareskog,et al. Citrullination is an inflammation-dependent process , 2006, Annals of the rheumatic diseases.
[4] Y. She,et al. Autocatalytic cleavage of myelin basic protein: an alternative to molecular mimicry. , 2005, Biochemistry.
[5] M. Mehler,et al. Combinatorial Profiles of Oligodendrocyte-Selective Classes of Transcriptional Regulators Differentially Modulate Myelin Basic Protein Gene Expression , 2005, The Journal of Neuroscience.
[6] P. Thompson,et al. Kinetic characterization of protein arginine deiminase 4: a transcriptional corepressor implicated in the onset and progression of rheumatoid arthritis. , 2005, Biochemistry.
[7] S. Barnum,et al. Expression of citrullinated proteins in murine experimental autoimmune encephalomyelitis , 2005, The Journal of comparative neurology.
[8] Anne E Carpenter,et al. In Vivo HP1 Targeting Causes Large-Scale Chromatin Condensation and Enhanced Histone Lysine Methylation , 2005, Molecular and Cellular Biology.
[9] P. Casaccia‐Bonnefil,et al. Histone modifications affect timing of oligodendrocyte progenitor differentiation in the developing rat brain , 2005, The Journal of cell biology.
[10] F. Mastronardi,et al. Molecules affecting myelin stability: A novel hypothesis regarding the pathogenesis of multiple sclerosis , 2005, Journal of neuroscience research.
[11] L. Kinnunen,et al. NF-κB Is Transported into the Nucleus by Importin α3 and Importin α4* , 2005, Journal of Biological Chemistry.
[12] G. Scalabrino. Cobalamin (vitamin B12) in subacute combined degeneration and beyond: traditional interpretations and novel theories , 2005, Experimental Neurology.
[13] R. Denman. PAD: the smoking gun behind arginine methylation signaling? , 2005, BioEssays : news and reviews in molecular, cellular and developmental biology.
[14] L. Klareskog,et al. Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity , 2005, Arthritis research & therapy.
[15] W. Bruck,et al. Expression of Stathmin, a Developmentally Controlled Cytoskeleton-Regulating Molecule, in Demyelinating Disorders , 2005, The Journal of Neuroscience.
[16] W. Brooks. Autoimmune disorders result from loss of epigenetic control following chromosome damage. , 2005, Medical hypotheses.
[17] Steven Clarke,et al. Human PAD4 Regulates Histone Arginine Methylation Levels via Demethylimination , 2004, Science.
[18] Paul Tempst,et al. Histone Deimination Antagonizes Arginine Methylation , 2004, Cell.
[19] C. Allis,et al. Dynamic alterations of specific histone modifications during early murine development , 2004, Journal of Cell Science.
[20] M. Ameloot,et al. Cytokine‐induced cell death in human oligodendroglial cell lines: I. Synergistic effects of IFN‐γ and TNF‐α on apoptosis , 2004 .
[21] M. Ameloot,et al. Cytokine‐induced cell death in human oligodendroglial cell lines. II: Alterations in gene expression induced by interferon‐γ and tumor necrosis factor‐α , 2004, Journal of neuroscience research.
[22] J. Boggs,et al. Attenuation of Experimental Autoimmune Encephalomyelitis and Nonimmune Demyelination by IFN-β plus Vitamin B12: Treatment to Modify Notch-1/Sonic Hedgehog Balance 1 , 2004, The Journal of Immunology.
[23] W. V. van Venrooij,et al. Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages , 2004, Annals of the rheumatic diseases.
[24] M. Ameloot,et al. Cytokine-induced cell death in human oligodendroglial cell lines: I. Synergistic effects of IFN-gamma and TNF-alpha on apoptosis. , 2004, Journal of neuroscience research.
[25] E. Vossenaar,et al. PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.
[26] O. Vaarala,et al. Peptidylarginine deiminase, the arginine to citrulline converting enzyme, is frequently recognized by sera of patients with rheumatoid arthritis, systemic lupus erythematosus and primary Sjögren syndrome , 2003, Scandinavian journal of rheumatology.
[27] J. Boggs,et al. The amount of sonic hedgehog in multiple sclerosis white matter is decreased and cleavage to the signaling peptide is deficient , 2003, Multiple sclerosis.
[28] T. Mimori,et al. High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis , 2003, Scandinavian journal of rheumatology.
[29] Yusuke Nakamura,et al. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis , 2003, Nature Genetics.
[30] Yusuke Nakamura,et al. Functional haplotypes of PADI 4 , encoding citrullinating enzyme peptidylarginine deiminase 4 , are associated with rheumatoid arthritis , 2003 .
[31] M. Yamada,et al. Nuclear Localization of Peptidylarginine Deiminase V and Histone Deimination in Granulocytes* , 2002, The Journal of Biological Chemistry.
[32] M. Muggironi,et al. Histone Deacetylase Activity Is Necessary for Oligodendrocyte Lineage Progression , 2002, The Journal of Neuroscience.
[33] C. Brosnan,et al. Multiple sclerosis: Re-expression of a developmental pathway that restricts oligodendrocyte maturation , 2002, Nature Medicine.
[34] F. Mastronardi,et al. Peptidylarginine deiminase: a candidate factor in demyelinating disease , 2002, Journal of neurochemistry.
[35] A. Nicholas,et al. Preparation of a monoclonal antibody to citrullinated epitopes: Its characterization and some applications to immunohistochemistry in human brain , 2002, Glia.
[36] H. Hirano,et al. Deimination of arginine residues in nucleophosmin/B23 and histones in HL-60 granulocytes. , 2002, Biochemical and biophysical research communications.
[37] D. Reinberg,et al. Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails. , 2001, Genes & development.
[38] M.,et al. The Isolation , Characterization , and Lipid-aggregating Properties of a Citrulline Containing Myelin Basic Protein * , 2001 .
[39] W. Cammer. Effects of TNFα on immature and mature oligodendrocytes and their progenitors in vitro , 2000, Brain Research.
[40] G. Harauz,et al. Deimination of myelin basic protein. 1. Effect of deimination of arginyl residues of myelin basic protein on its structure and susceptibility to digestion by cathepsin D. , 2000, Biochemistry.
[41] S. Kamel‐Reid,et al. Co‐localization of Patched and activated Sonic hedgehog to lysosomes in neurons , 2000, Neuroreport.
[42] A. Kawada,et al. Molecular cloning of cDNAs of mouse peptidylarginine deiminase type I, type III and type IV, and the expression pattern of type I in mouse. , 2001, European journal of biochemistry.
[43] T. Senshu,et al. Localization of peptidylarginine deiminase type II in a stage-specific immature oligodendrocyte from rat cerebral hemisphere , 1999, Neuroscience Letters.
[44] J. Nalbantoglu,et al. p53 Induction by Tumor Necrosis Factor‐α and Involvement of p53 in Cell Death of Human Oligodendrocytes , 1999, Journal of neurochemistry.
[45] G. Kollias,et al. A tumor necrosis factor‐induced model of human primary demyelinating diseases develops in immunodeficient mice , 1999, European journal of immunology.
[46] G. Kollias,et al. Transgenic models of TNF induced demyelination. , 1999, Advances in experimental medicine and biology.
[47] S. Topino,et al. Immune-derived cytokines in the nervous system: epigenetic instructive signals or neuropathogenic mediators? , 1999, Critical reviews in immunology.
[48] P. Ye,et al. Insulin-like growth factor I protects oligodendrocytes from tumor necrosis factor-alpha-induced injury. , 1999, Endocrinology.
[49] G. Kollias,et al. Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy. , 1998, The American journal of pathology.
[50] C. Raine,et al. Multiple sclerosis: expression of molecules of the tumor necrosis factor ligand and receptor families in relationship to the demyelinated plaque. , 1998, Revue neurologique.
[51] H. Okano,et al. ICE/CED‐3 Family Executes Oligodendrocyte Apoptosis by Tumor Necrosis Factor , 1997, Journal of neurochemistry.
[52] A. Kawada,et al. Isolation and molecular cloning of epidermal- and hair follicle-specific peptidylarginine deiminase (type III) from rat. , 1997, Journal of biochemistry.
[53] G. Kollias,et al. Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. , 1997, Journal of immunology.
[54] C. Allis,et al. Histone Acetylation and Chromatin Assembly: A Single Escort, Multiple Dances? , 1996, Cell.
[55] J. Bilbao,et al. Acute multiple sclerosis (marburg type) is associated with developmentally immature myelin basic protein , 1996, Annals of neurology.
[56] B. Götz,et al. GLIAL CELL INTERACTIONS WITH TENASCIN-C: ADHESION AND REPULSION TO DIFFERENT TENASCIN-C DOMAINS IS CELL TYPE RELATED , 1996, International Journal of Developmental Neuroscience.
[57] J. Svaren,et al. Regulation of gene expression by nucleosomes. , 1996, Current opinion in genetics & development.
[58] C. Ackerley,et al. Modifications of myelin basic protein in DM20 transgenic mice are similar to those in myelin basic protein from multiple sclerosis. , 1996, The Journal of clinical investigation.
[59] G. Kollias,et al. Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[60] J. McLaurin,et al. A human glial hybrid cell line differentially expressing genes subserving oligodendrocyte and astrocyte phenotype. , 1995, Journal of neurobiology.
[61] Jack Antel,et al. Phenotypic Differences between Human Monocytes/Macrophages and Microglial Cells Studied In Situ and In Vitro , 1994, Journal of neuropathology and experimental neurology.
[62] C. Ackerley,et al. Myelin in multiple sclerosis is developmentally immature. , 1994, The Journal of clinical investigation.
[63] C. Ackerley,et al. Demyelination in a transgenic mouse: A model for multiple sclerosis , 1993, Journal of neuroscience research.
[64] M. Moscarello,et al. Deimination of Human Myelin Basic Protein by a Peptidylarginine Deiminase from Bovine Brain , 1993, Journal of neurochemistry.
[65] H. Takahara,et al. Three types of mouse peptidylarginine deiminase: characterization and tissue distribution. , 1991, Journal of biochemistry.
[66] E. Benveniste,et al. Differential tumor necrosis factor alpha expression by astrocytes from experimental allergic encephalomyelitis-susceptible and -resistant rat strains , 1991, The Journal of experimental medicine.
[67] C. Brosnan,et al. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. , 1991, The Journal of clinical investigation.
[68] C. Brosnan,et al. Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor. , 1990, Journal of immunology.
[69] S. Tagami,et al. Peptidylarginine deiminase of the mouse. Distribution, properties, and immunocytochemical localization. , 1989, The Journal of biological chemistry.
[70] T. Cruz,et al. Characterization of Myelin Fractions from Human Brain White Matter , 1985, Journal of neurochemistry.
[71] H. Towbin,et al. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.